Skip to content

TTRX - Turn Therapeutics Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Turn Therapeutics Inc. Common Stock

TTRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TTRXTurn Therapeutics Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $11.69
52-wk low: $2.57
Prev close: $6.95
Mkt cap: $298.2M
P/B: 441.7x
Profit margin: +0.0%

Smart money

4 funds hold a position.

Real smart money

Funds holding this stock

4 holders

Combined position$1.0M

MI
Millennium
Israel Englander · Q2 2026 13F
$442K
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in $0.05 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $298M

Valuation

P/B441.66

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TTRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $298.21M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-686.0%

$189K

position

BR

BlackRock

Q2 2026 13F

$282K

position

1 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 1 holders

Coverage gaps for TTRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.07-$0.05

-$0.02 expected

Next report

What the street expects next

EPS expected

-$0.09

-$0.09 to -$0.09

Revenue expected

$0.00

1 analysts

Estimate drift

0.09

Change in 30 days

-686.0%

ROA-50.3%

Growth